Coegin Pharma AB reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was SEK 4.54 million compared to SEK 2.04 million a year ago. Net loss was SEK 7.79 million compared to SEK 1.61 million a year ago. Basic loss per share from continuing operations was SEK 0.013 compared to SEK 0.003 a year ago. Diluted loss per share from continuing operations was SEK 0.013 compared to SEK 0.003 a year ago.